Progen Co., Ltd. (XKON:296160)
2,815.00
-15.00 (-0.53%)
At close: Jul 21, 2026
Progen Market Cap
Progen has a market cap or net worth of 43.28 billion as of July 21, 2026. Its market cap has decreased by -62.38% in one year.
Market Cap
43.28B
Enterprise Value
n/a
Revenue
450.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
2,815.00
ChartMarket Cap Chart
Since November 15, 2023, Progen's market cap has decreased from 46.33B to 43.28B, a decrease of -6.57%. That is a compound annual growth rate of -2.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 43.28B | -62.67% |
| Dec 30, 2025 | 115.93B | 28.30% |
| Dec 30, 2024 | 90.36B | 9.39% |
| Dec 28, 2023 | 82.60B | 78.30% |
| Nov 15, 2023 | 46.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Naturalendo Tech | 56.64B |
| IMGT Co.,Ltd. | 55.14B |
| Aptamer Sciences | 52.01B |
| TegoScience | 51.64B |
| Psomagen | 50.40B |
| ADBiotech | 49.10B |
| J2KBIO | 45.84B |
| Parataxis Korea | 44.13B |